ArticleFrontiers in oncology2021

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.

Oscar Arrieta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.